A carregar...
Publicação
I2 therapeutics: business plan
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 3.51 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Cancer is a leading cause of death world wide. Despite Big Pharma companies spending high amounts of resources on Research and Development of new drugs, their effectiveness leaves much to be desired. Our biotech start up “I2 Therapeutics” addresses this gap in the market with a novel science-based solution called Syderum. Syderum is a system for targeted drug delivery to cancer cells whiles paring healthy tissue. Thus, harmful side effects of chemotherapy can be alleviated, and patient’s lives can be improved. The implications of this piece of work are foundation a las going for ward with this company could provide significantly better care for a large portion of the patient population and an advance men of the economic and social conditions in the communities in which I2 Therapeutics operates.
Descrição
Palavras-chave
Entrepreneurship Venture capital Science Leadership Innovation R&D Entrepreneurial finance